Christopher D. Herzog

Gene delivery of neurturin to putamen and substantia nigra in <scp>P</scp>arkinson disease: A double‐blind, randomized, controlled trial

C. Warren Olanow, Raymond T. Bartus, Tiffany Baumann et al. · Annals of Neurology · 2015 · 277 citations

Delivery of neurturin by AAV2 (CERE‐120)‐mediated gene transfer provides structural and functional neuroprotection and neurorestoration in MPTP‐treated monkeys

Jeffrey H. Kordower, Christopher D. Herzog, Biplob Dass et al. · Annals of Neurology · 2006 · 253 citations

A phase1 study of stereotactic gene delivery of AAV2‐NGF for Alzheimer's disease

Michael S. Rafii, Tiffany Baumann, Roy A.E. Bakay et al. · Alzheimer s & Dementia · 2014 · 220 citations · Full text

Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients

Raymond T. Bartus, Tiffany Baumann, João Siffert et al. · Neurology · 2013 · 205 citations · Full text

Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brains

Raymond T. Bartus, Christopher D. Herzog, Yaping Chu et al. · Movement Disorders · 2010 · 167 citations